Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA

Podobne zapisy

• Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients
  od: Hamann, Philip D H, i wsp.
  Wydane: (2019)
• Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis
  od: Hamann, Philip D H, i wsp.
  Wydane: (2019)
• The BSRBR-RA at 15 years Strap line: Providing Real-World Insight into the Effectiveness and Safety of Biologic Therapies
  od: Dennison, Elaine M, i wsp.
  Wydane: (2016)
• Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data
  od: Hawley, Samuel, i wsp.
  Wydane: (2019)
• Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
  od: Dixon, W G, i wsp.
  Wydane: (2009)